ICICI Prudential Pharma Healthcare and Diagnostics Fund holds 38 instruments (97.17% equity), led by Sun Pharmaceutical Industries Limited (12.69%), Dr. Reddy's Laboratories Limited (8.45%) and Cipla Limited (6.56%), as of its 31 July 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of ICICI Prudential Pharma Healthcare and Diagnostics Fund, managed by ICICI Prudential Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 38 instruments with an equity allocation of 97.17%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
ICICI Prudential Pharma Healthcare and Diagnostics Fund's top 10 holdings account for 60.26% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 89.2% of net assets, spread across 4 sectors in total. Since its 30 June 2026 disclosure, the fund added 2 new positions and exited 2 positions, with Biocon Limited seeing the largest move (+2.38pp to 4.97%).
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Biocon Limited | 2.59% → 4.97% | ▲ +2.38 |
| AstraZeneca Pharma India Limited | 0.82% → 1.86% | ▲ +1.04 |
| Blue Jet Healthcare Limited | 1.51% → 2.39% | ▲ +0.88 |
| Sun Pharmaceutical Industries Limited | 12.2% → 12.69% | ▲ +0.49 |
| Divi's Laboratories Limited | 5.57% → 6.03% | ▲ +0.46 |
| Syngene International Limited | 2.89% → 3.26% | ▲ +0.37 |
| Dr. Reddy's Laboratories Limited | 8.22% → 8.45% | ▲ +0.23 |
| Abbott India Limited | 2.47% → 2.63% | ▲ +0.16 |
| Medplus Health Services Limited | 3.66% → 3.8% | ▲ +0.14 |
| Pfizer Limited | 1.86% → 1.97% | ▲ +0.11 |
| Stock | Weight | Change |
|---|---|---|
| Mankind Pharma Limited | 6.98% → 5.47% | ▼ -1.51 |
| Alkem Laboratories Limited | 5.67% → 5.11% | ▼ -0.56 |
| Cohance Lifesciences Limited | 4.31% → 3.92% | ▼ -0.39 |
| Aurobindo Pharma Limited | 1.17% → 0.81% | ▼ -0.36 |
| Thyrocare Technologies Limited | 2.24% → 1.95% | ▼ -0.29 |
| Max Healthcare Institute Limited | 3.1% → 2.81% | ▼ -0.29 |
| Alivus Life Sciences Limited | 1.54% → 1.33% | ▼ -0.21 |
| Akums Drugs and Pharmaceuticals Limited | 2.05% → 1.89% | ▼ -0.16 |
| Hikal Limited | 1.34% → 1.18% | ▼ -0.16 |
| Alembic Pharmaceuticals Limited | 2.58% → 2.43% | ▼ -0.15 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: ICICI Prudential Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.